BEGIN:VCALENDAR VERSION:2.0 PRODID:PHP BEGIN:VEVENT DTSTART:20210715 SUMMARY:Epigenetic Therapeutic Targets DESCRIPTION:
Zenith will be presenting at the Epigenetic Therapeutic Targets digital event on July 15. More info can be found HERE.
"Clinical Development of The BET Bromodomain Inhibitor ZEN-3694 In Solid Tumors: Lessons Learned"
• Design of epigenetic combinatorial therapies
• Clinical activity in breast and prostate cancer patients
• Mechanisms of action: similarities and differences between the prostate
and breast cancer trials